Download video

Clinical Trials Part 7: Approval Process in the EU and Canada – What U.S. Sponsors Need to Know

1.6K views

Medmarc

2 months ago

Clinical Trials Part 7: Approval Process in the EU and Canada – What U.S. Sponsors Need to Know

Clinical Trials Part 7: Approval Process in the EU and Canada – What U.S. Sponsors Need to Know

Real-world efficacy of second-line cabozantinib in renal cell carcinoma
0:40
Real-world efficacy of second-line cabozantinib in renal cell carcinoma
by VJOncology
HER2 results are equivoval 2+ IHC with boderline HER2 gene copy number, how can this be resolved?
10:42
HER2 results are equivoval 2+ IHC with boderline HER2 gene copy number, how can this be resolved?
by PRECISCA
Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH
1:07
Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH
by VJHemOnc – Video Journal of Hematology \& HemOnc
Venous Insufficiency — Part 2: Diagnosis and Treatment
7:57
Venous Insufficiency — Part 2: Diagnosis and Treatment
by The Learning Stethoscope
Canadian Rare Disease Symposium 2025 | Part II: Preparing for Clinical Trials
2:48:00
Canadian Rare Disease Symposium 2025 | Part II: Preparing for Clinical Trials
by Stem Cell Network - Réseau de cellules souches
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3:02
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
by Global Resource for Advancing Cancer Education
Glofitamab monotherapy achieves durable responses in R\/R DLBCL: three-year follow-up of NP30179
5:59
Glofitamab monotherapy achieves durable responses in R\/R DLBCL: three-year follow-up of NP30179
by VJHemOnc – Video Journal of Hematology \& HemOnc
A New Paradigm in the Detection of Amyloid Pathology: The Emergence of Highly Accurate Blood Tests
1:00:22
A New Paradigm in the Detection of Amyloid Pathology: The Emergence of Highly Accurate Blood Tests
by C2N Diagnostics
Insights into the Phase II WINDOW-2 trial
0:50
Insights into the Phase II WINDOW-2 trial
by VJHemOnc – Video Journal of Hematology \& HemOnc
Part 2: Progress in Treatments
2:52
Part 2: Progress in Treatments
by videocsbcy
Adherence Matters: The Key to Optimizing Clinical Outcomes (1st Announcement)
0:54
Adherence Matters: The Key to Optimizing Clinical Outcomes (1st Announcement)
by P2PMD
7th CPC P2 HD Version
2:51:43
7th CPC P2 HD Version
by ClinicoPathological Chronicles
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
31:07
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
by Global Resource for Advancing Cancer Education
Updates from the Phase II trials of glofitamab and epcoritamab for R\/R LBCL
1:49
Updates from the Phase II trials of glofitamab and epcoritamab for R\/R LBCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Evaluating clinical studies ck2
13:04
Evaluating clinical studies ck2
by Dr kevin
#Phase2 CLINICALTRIALS#clinicaltrialphaseFUNDAMENTALS OF PHASE 2#shorts
4:21
#Phase2 CLINICALTRIALS#clinicaltrialphaseFUNDAMENTALS OF PHASE 2#shorts
by Clinical pathway
Top Cardiology Trials of 2022
17:52
Top Cardiology Trials of 2022
by Medscape
【Key Message】Early Optimal Glycemic Control: a Necessity to Prevent T2D Complications
10:52
【Key Message】Early Optimal Glycemic Control: a Necessity to Prevent T2D Complications
by P2PMD